N R Hackett - JoVE Visualize

Showing results (41-50 of 51) with videos related to

Pageof 6

Sort By:

American Journal of Respiratory Cell and Molecular Biology|February 25, 1999

Modification of the genetic program of human alveolar macrophages by adenovirus vectors in vitro is feasible but inefficient, limited in part by the low level of expression of the coxsackie/adenovirus receptorR J Kaner, S Worgall, P L Leopold, et al.

AJNR. American Journal of Neuroradiology|August 19, 2007

Assessing disease severity in late infantile neuronal ceroid lipofuscinosis using quantitative MR diffusion-weighted imagingJ P Dyke, H U Voss, D Sondhi, et al.

Neurology|August 8, 2007

Neurological deterioration in late infantile neuronal ceroid lipofuscinosisS Worgall, M V Kekatpure, L Heier, et al.

Human Gene Therapy|June 12, 1999

Safety of direct myocardial administration of an adenovirus vector encoding vascular endothelial growth factor 121S R Patel, L Y Lee, C A Mack, et al.

Human Gene Therapy|January 1, 1997

Circumvention of anti-adenovirus neutralizing immunity by administration of an adenoviral vector of an alternate serotypeC A Mack, W R Song, H Carpenter, et al.

The Annals of Thoracic Surgery|February 2, 2000

Focal angiogen therapy using intramyocardial delivery of an adenovirus vector coding for vascular endothelial growth factor 121L Y Lee, S R Patel, N R Hackett, et al.

The Journal of Clinical Investigation|November 5, 1999

Airway epithelial CFTR mRNA expression in cystic fibrosis patients after repetitive administration of a recombinant adenovirusB G Harvey, P L Leopold, N R Hackett, et al.

Gene Therapy|July 30, 2005

AAV2-mediated CLN2 gene transfer to rodent and non-human primate brain results in long-term TPP-I expression compatible with therapy for LINCLD Sondhi, D A Peterson, E L Giannaris, et al.

Nature Medicine|November 2, 2001

Impaired recruitment of bone-marrow-derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growthD Lyden, K Hattori, S Dias, et al.

Circulation|August 3, 1999

Angiogenesis gene therapy: phase I assessment of direct intramyocardial administration of an adenovirus vector expressing VEGF121 cDNA to individuals with clinically significant severe coronary artery diseaseT K Rosengart, L Y Lee, S R Patel, et al.

Pageof 6

Showing results (41-50 of 51) with videos related to

Sort By:

Pageof 6

American Journal of Respiratory Cell and Molecular Biology|February 25, 1999

Modification of the genetic program of human alveolar macrophages by adenovirus vectors in vitro is feasible but inefficient, limited in part by the low level of expression of the coxsackie/adenovirus receptorR J Kaner, S Worgall, P L Leopold, et al.

AJNR. American Journal of Neuroradiology|August 19, 2007

Assessing disease severity in late infantile neuronal ceroid lipofuscinosis using quantitative MR diffusion-weighted imagingJ P Dyke, H U Voss, D Sondhi, et al.

Neurology|August 8, 2007

Neurological deterioration in late infantile neuronal ceroid lipofuscinosisS Worgall, M V Kekatpure, L Heier, et al.

Human Gene Therapy|June 12, 1999

Safety of direct myocardial administration of an adenovirus vector encoding vascular endothelial growth factor 121S R Patel, L Y Lee, C A Mack, et al.

Human Gene Therapy|January 1, 1997

Circumvention of anti-adenovirus neutralizing immunity by administration of an adenoviral vector of an alternate serotypeC A Mack, W R Song, H Carpenter, et al.

The Annals of Thoracic Surgery|February 2, 2000

Focal angiogen therapy using intramyocardial delivery of an adenovirus vector coding for vascular endothelial growth factor 121L Y Lee, S R Patel, N R Hackett, et al.

The Journal of Clinical Investigation|November 5, 1999

Airway epithelial CFTR mRNA expression in cystic fibrosis patients after repetitive administration of a recombinant adenovirusB G Harvey, P L Leopold, N R Hackett, et al.

Gene Therapy|July 30, 2005

AAV2-mediated CLN2 gene transfer to rodent and non-human primate brain results in long-term TPP-I expression compatible with therapy for LINCLD Sondhi, D A Peterson, E L Giannaris, et al.

Nature Medicine|November 2, 2001

Impaired recruitment of bone-marrow-derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growthD Lyden, K Hattori, S Dias, et al.

Circulation|August 3, 1999

Angiogenesis gene therapy: phase I assessment of direct intramyocardial administration of an adenovirus vector expressing VEGF121 cDNA to individuals with clinically significant severe coronary artery diseaseT K Rosengart, L Y Lee, S R Patel, et al.

Pageof 6